Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy.
about
Application of desorption electrospray ionization mass spectrometry imaging in breast cancer margin analysisA Study of the Growth Patterns of Breast Carcinoma Using 3D Reconstruction: A Pilot Study.Integrated optical coherence tomography and microscopy for ex vivo multiscale evaluation of human breast tissues.Standardized and reproducible methodology for the comprehensive and systematic assessment of surgical resection margins during breast-conserving surgery for invasive breast cancerImpact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial.Ipsilateral breast tumor recurrence following breast-conserving surgery for early-stage invasive cancer.Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy.The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy.The effect of simultaneous peripheral excision in breast conservation upon margin statusThe rationale of surgical treatment of invasive breast cancer and decision making of surgical procedures.Computer-aided detection (CAD) system for breast MRI in assessment of local tumor extent, nodal status, and multifocality of invasive breast cancers: preliminary study.Quality of diagnosis and surgical management of breast lesions in a community hospital: room for improvement?A review of current practices in breast conservation surgery in the UK.[Oncoplastie with breast conservation in breast cancer treatment: about 16 cases].Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving Surgery.Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence.Breast conservation: evolution of surgical strategies.Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer.Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized studyVariability in the quality of pathology reporting of margin status following breast cancer surgeryPreoperative localization and surgical margins in conservative breast surgery.Evaluation of single nucleotide polymorphisms (SNPs) in the p53 binding protein 1 (TP53BP1) gene in breast cancer patients treated with breast-conserving surgery and whole-breast irradiation (BCS + RT).Impact of margin assessment method on positive margin rate and total volume excised.A randomized prospective study of lumpectomy margin assessment with use of MarginProbe in patients with nonpalpable breast malignancies.Intraoperative frozen section analysis of margins in breast conserving surgery significantly decreases reoperative rates: one-year experience at an ambulatory surgical center.Comparison of magnetic resonance imaging and multidetector computed tomography for evaluating intraductal tumor extension of breast cancer.Predicting local recurrence following breast-conserving therapy for early stage breast cancer: the significance of a narrow (≤ 2 mm) surgical resection margin.Breast-conserving therapy for early-stage breast cancer in Chinese women: a meta-analysis of case-control studies.Overview of breast cancer treatment and reconstruction for primary care providers.The role of margin status and reexcision in local recurrence following breast conservation surgery.The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis.Pathologic-radiologic correlation in evaluation of retroareolar margin in nipple-sparing mastectomy.Surgical margins in the veterinary cancer patient.Enhancing surgical vision by using real-time imaging of αvβ3-integrin targeted near-infrared fluorescent agent.Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor.The Usefulness of Intraoperative Circumferential Frozen-Section Analysis of Lumpectomy Margins in Breast-Conserving Surgery.DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes.Multi-channel LED light source for fluorescent agent aided minimally invasive surgery.Extent of ductal carcinoma in situ within and surrounding invasive primary breast carcinoma.Microsatellite analysis of breast carcinoma and corresponding local recurrences.
P2860
Q30414017-794CE612-F117-4212-8488-DB86C8ADACE7Q30490346-BE471F8B-A108-48D7-A4BC-3F742EC13750Q30498000-1C924E5D-8D20-46ED-853E-12B1C66D8173Q33487487-39C535FD-107C-48EB-850A-0DFB60FB5DECQ33561153-463EFCD6-4629-4F1C-B194-69DDD111B0C8Q33804667-F671A8C5-04C6-44D9-853A-3D952246D057Q33825299-E5FEAE76-FAC9-4B72-95A9-3ABD076020A8Q33853196-83FB88E7-9AE4-4210-8BF6-64DA25D0A8C1Q34138675-F9540F9F-2468-433E-8483-8098ED2A511CQ35008163-8EF36D58-2424-43E8-AED0-110AE7ADC160Q35132131-F096076D-C508-4B6C-87A2-321816045DF2Q35517563-DBAE2F71-A6C3-4634-96DA-E2A5293A6BB9Q35971024-265DD939-8962-426F-BD2F-4FB9DBA877EBQ36080453-1CC6A98E-166E-470B-BC59-94CD87F8EB07Q36095773-60FB83D4-FE21-4ADF-86E3-EB094A25DB94Q36115781-50851441-7475-4DED-9E2B-5182D0CC1910Q36588421-FB67D3E8-6457-402E-A613-3F9499EE2578Q36614796-559199B9-AA0A-4397-84CA-C55B043DAED7Q36622439-751B10E5-ABB2-4DF7-BFDF-F8B71FE7C549Q36865712-99DB13A6-E867-4F7D-AC61-3853713061E2Q37108780-05EC3441-BF54-4B5C-8349-C1FF2C21390EQ37421810-9A4845BC-7561-4B82-BAB7-41386B5F3ED3Q37582500-5EB39578-08F5-4569-9B99-F7BD4DEE9C51Q37683529-3B21A253-EC28-4B3D-B43C-7D3648203877Q37705813-8F8B8E3B-B4A7-4795-BC57-26F3FF0C0FE2Q37802801-1CEFC839-3B1B-44A2-A707-5D986A99717DQ37845304-0E327DB6-D01B-4019-BFB0-7ED45A6DD1F6Q37993375-C00D9709-83EE-4246-8E28-A002933490F4Q38065341-8356D57F-5D8C-4294-B27F-CF5B8BC14A77Q38107803-B3B291DB-FE3A-4661-BDBF-1061FAB3B902Q38182847-08C69DE5-8E80-4132-B0E4-39275761B3E6Q38312153-45BB142D-9464-46E8-9413-7659F0FF1180Q38757865-B8415492-9D18-4546-9FC7-199C25BAF955Q39555319-53A3562C-8205-4D19-8C14-408D42B35E77Q40431456-525DCC87-C3CC-4F6C-B6C0-707D91FDC1ECQ40953823-29568A24-0AEA-4E7F-AAA7-AA7FC457A96AQ41721847-49D80FA1-C6C2-4699-BE37-6CF32CE5A825Q41827489-8DC120FB-6FDD-469B-A21F-947E347E9886Q43751760-533A254E-C19F-4782-8F87-7D73EA12B583Q44141759-E4535757-8576-46D4-98B8-5FB4E7AB839C
P2860
Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Pathologic margin involvement ...... ith breast-conserving therapy.
@en
type
label
Pathologic margin involvement ...... ith breast-conserving therapy.
@en
prefLabel
Pathologic margin involvement ...... ith breast-conserving therapy.
@en
P2093
P2860
P1433
P1476
Pathologic margin involvement ...... ith breast-conserving therapy.
@en
P2093
Connolly JL
Eberlein T
Schnitt SJ
P2860
P304
P356
10.1002/(SICI)1097-0142(19961101)78:9<1921::AID-CNCR12>3.0.CO;2-#
P407
P577
1996-11-01T00:00:00Z